You are here

BCRF Grantee Since


Donor Recognition

The Play for P.I.N.K. Award

Area(s) of Focus

Sharon H. Giordano, MD, MPH

Chair, Department of Health Services Research
Interim Chair, Department of Health Disparities
Professor of Medicine,
Department of Breast Medical Oncology
University of Texas MD Anderson Cancer Center
Houston, TX

Current Research

Male Breast Cancer (BC) is a rare disease accounting for less than 1% of all BC. Knowledge about male BC is scarce, and treatment and management is based on female BC. To better characterize this disease and ultimately develop specific treatments and improve outcomes for men with BC, the Male Breast Cancer International Program was created. Dr. Giordano is part of a team of BCRF grantees participating in this worldwide effort coordinated by the European Organization for the Research and Treatment of Cancer (EORTC), with the help of the Translational Breast Cancer Research Consortium (TBCRC), and run under the network of the Breast International Group (BIG) and the North American Breast Cancer Groups  (NABCG). This Program has three parts. Part One is a retrospective joint analysis of clinical data and tumor samples from 1822 male breast cancer patients treated in the last 20 years in 23 centers from 9 countries, the largest series of male breast cancer ever studied. The first results of the retrospective study were presented at the San Antonio Breast Cancer Symposium in 2014. Part Two of the study is focused on creating a registry of all male breast cancer patients treated within the EORTC/TBCRC/BIG/NABCG global network and includes collection of biological material that can be used for future studies.  This part of the study is ongoing with over 100 patients included. The researchers are currently conducting in-depth biological characterization of the samples. Part Three is a prospective clinical trial, expected to open in late 2015, that will evaluate a new drug to treat male breast cancer. This important work will lead to the development of better treatment strategies for male breast cancer. 


Sharon Giordano is a Professor with tenure at The University of Texas MD Anderson Cancer Center in the Department of Breast Medical Oncology, Chair of the Department of Health Services Research, and Ad Interim Chair of Health Disparities Research.

Dr. Giordano received her undergraduate degree from Yale University and graduated Summa Cum Laude and With Distinction in Biology. She received her MD degree from The Johns Hopkins School of Medicine in 1996. She is a board certified Medical Oncologist. In 2004, Dr. Giordano received a Master of Public Health degree in Disease Control from The University of Texas School of Public Health.

Dr. Giordano’s research interests include breast cancer outcomes research, late effects of treatment, and male breast cancer. She is currently funded through CPRIT, Susan Komen for the Cure, and AHRQ.

Dr. Giordano has received awards including the Faculty Educator of the Month (2009), the Distinguished Alumnus Award (2010), Mentor of the Year Award (2011), Teaching Department of the Year (2011, 2013), and Faculty Scholar Award (2012). Dr. Giordano is the past Track Leader for the ASCO Health Services Program Committee, past member of the ASCO Education Committee, and is a current member and chair of the ASCO Clinical Practice Guidelines Committee. She also serves on the National Comprehensive Cancer Network Breast Cancer Guidelines Committee.